Finanzas de Skinhealth Systems Inc (SKIN)SKINSkinhealth Systems Inc

Skinhealth Systems Inc (SKIN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 74.7% of total sales, equivalent to $53.86M. Another important revenue stream is Delivery Systems. Understanding this composition is critical for investors evaluating how SKIN navigates market cycles within the Personal Products industry.

Evaluating the bottom line, Skinhealth Systems Inc maintains a gross margin of 68.42%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 4.95%, while the net margin is -3.70%. These profitability ratios, combined with a Return on Equity (ROE) of -43.89%, provide a clear picture of how effectively SKIN converts its operational activities into shareholder value.

In the context of the broader market, SKIN competes directly with industry leaders such as ECOR and CRDF. With a market capitalization of $101.91M, it holds a leading position in the sector. When comparing efficiency, SKIN's gross margin of 68.42% stands against ECOR's 88.47% and CRDF's 100.00%. Such benchmarking helps identify whether Skinhealth Systems Inc is trading at a premium or discount relative to its financial performance.

The company's recent financial performance shows fluctuations in revenue and net income, with Q2 2026 revenue at $72.11 million but a net loss of $2.67 million. The gross margin has been relatively stable, around 68%, but the company has faced significant net losses in recent quarters.